FDA NDC Directory · JSON-LD · Markdown

sfRowasa Sulfite-Free Formulation

NDC 0037-0022 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namemesalamine
Labeler / ManufacturerViatris Specialty LLC
Marketing categoryNew Drug Application (innovator) · App NDA019618
Dosage form / routeSUSPENSION · RECTAL
Active ingredientsMESALAMINE (4 g/60mL)
Marketing started20160324
Marketing ended20260731
Package count2

External sources

Source: openFDA. Public-domain (CC0).